Th9 Cells: Probable players in ulcerative colitis pathogenesis.

Area of Science:

• Immunology
• Gastroenterology

Background:

• T lymphocytes are crucial for adaptive immunity, with CD4+ T cells activating inflammatory responses.
• Helper T cell subtypes vary based on inflammation type and site.
• Th9 cells, a recently identified helper T lymphocyte subset, produce interleukin-9 (IL-9).

Purpose of the Study:

• To discuss the latest knowledge on Th9 cells and their role in ulcerative colitis (UC).
• To explore the potential of Th9 cells in gut pathogenesis and novel therapeutic approaches for inflammatory bowel disease (IBD).

Main Methods:

• Naive T cells differentiate into Th9 cells upon exposure to IL-4 and TGF-β, with transcription factors IRF4 and Smads being essential.
• Investigating the presence and activity of Th9 cells and IL-9 in UC models and human subjects.

Main Results:

• Th9 cells and IL-9 overexpression have been observed in the inflammatory environment of UC.
• Excessive IL-9 may compromise epithelial barriers and tolerance to gut microbiota, contributing to inflammation.
• The precise role of Th9 cells in UC pathogenesis requires further exploration.

Conclusions:

• Th9 cells are a significant factor in UC, producing IL-9 and potentially exacerbating gut inflammation.
• Further research into Th9 cell function in UC pathogenesis is critical for developing targeted therapies for IBD.